Our executive team’s individual backgrounds total over 150 years of experience in diagnostics, including expertise in central lab instrumentation, point-of-care devices, user interface design and all aspects of the development process. Top it off with 25 years of finance chops and many, many successful platform and product launches. That’s who will be bringing our platform’s benefits to on-site diagnostics.
A team committed to bringing the benefits of immediate on-site Therapeutic Drug Monitoring to patients in the US.
-
-
Larry Mimms
CEO and CSO
-
-
-
-
-
Valerie Day
SVP, Product Development and Operations
-
Michael Hale
VP, Research and Development
-
David Booker
Senior Director, Automation and Instrumentation
-
Kurt Bray
Senior Director, Clinical Development and Regulatory Affairs
Learn How to Take Control
Submit your information below so we can analyze your existing Theraputic Drug Monitoring and how you can take control of treatments, costs and patient satisfaction.